Thomas G. Gleason

Dr. Thomas Gleason is currently a senior surgeon with Asheville Heart and has distinguished clinical and research expertise in both thoracic aortic and valvular heart disease. His clinical research interests have included the development and refinement of novel valve therapies, particularly aortic valve repair strategies, the study of thoracic aortic diseases, especially bicuspid aortic valve associated aortopathy, and refinement of a systematic approach toward the management of aortic dissections with a distinct focus on neurocerebral malperfusion and neurologic outcomes.

His longstanding basic science research interest has been devoted to the study of ascending aortopathies and aortic dissection, particularly that associated with congenital bicuspid aortic valve (BAV). His research on BAV aortopathy has been supported by the National Heart, Lung and Blood Institute of the National Institutes of Health for many years. He currently serves on the Board of Directors of the Society of Thoracic Surgeons as well as the National Steering Committee for the STS/ACC TVT Registry and is co-Chair of the Research and Publications Committee for the TVT.